Back
UroGen Pharma Vs. Amicus Therapeutics Industry Stock Comparison
Sell
22
URGN
UroGen Pharma
Last Price:
$10.66
Seasonality Move:
-3.79%
Sell
44
FOLD
Amicus Therapeutics
Last Price:
$9.81
Seasonality Move:
5.47%
Sell
22
UroGen Pharma (URGN)
is a Sell
Is UroGen Pharma a Buy, Sell or Hold?
-
The current UroGen Pharma [URGN] share price is $10.67. The Score for URGN is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
-
The current Amicus Therapeutics [FOLD] share price is $9.80. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
URGN Stock Price Chart
What is UroGen Pharma's stock price today?
-
The UroGen Pharma share price today is $10.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight selling pressure.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $9.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.
URGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 30.29 | Sell |
Chaikin Money Flow: | -612616 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.1 - 12.42) | Sell |
Bollinger Bands (100): | (11.7 - 14.2) | Sell |
FOLD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 45.87 | Sell |
Chaikin Money Flow: | 1508811 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.59 - 9.99) | Buy |
Bollinger Bands (100): | (9.99 - 11.55) | Sell |
URGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.14 | Sell |
20-day SMA: | 11.89 | Sell |
50-day SMA: | 12.03 | Sell |
200-day SMA: | 13.95 | Sell |
8-day EMA: | 11.14 | Sell |
20-day EMA: | 11.58 | Sell |
50-day EMA: | 12.09 | Sell |
200-day EMA: | 13.45 | Sell |
FOLD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.82 | Sell |
20-day SMA: | 9.84 | Sell |
50-day SMA: | 10.45 | Sell |
200-day SMA: | 10.64 | Sell |
8-day EMA: | 9.79 | Buy |
20-day EMA: | 9.9 | Sell |
50-day EMA: | 10.25 | Sell |
200-day EMA: | 10.81 | Sell |
UroGen Pharma Earnings Growth & URGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.19 per share.
UroGen Pharma Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amicus Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |